2.53
price up icon7.66%   0.18
after-market After Hours: 2.53
loading
Minerva Neurosciences Inc stock is traded at $2.53, with a volume of 83,417. It is up +7.66% in the last 24 hours and up +16.06% over the past month. Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
See More
Previous Close:
$2.35
Open:
$2.38
24h Volume:
83,417
Relative Volume:
0.50
Market Cap:
$17.69M
Revenue:
-
Net Income/Loss:
$-33.65M
P/E Ratio:
-0.5685
EPS:
-4.45
Net Cash Flow:
$-20.83M
1W Performance:
+18.25%
1M Performance:
+16.06%
6M Performance:
+74.48%
1Y Performance:
-3.07%
1-Day Range:
Value
$2.2378
$2.55
1-Week Range:
Value
$2.12
$3.2899
52-Week Range:
Value
$1.15
$3.2899

Minerva Neurosciences Inc Stock (NERV) Company Profile

Name
Name
Minerva Neurosciences Inc
Name
Phone
617-600-7373
Name
Address
1601 TRAPELO ROAD, WALTHAM, MA
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
NERV's Discussions on Twitter

Compare NERV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NERV
Minerva Neurosciences Inc
2.53 16.43M 0 -33.65M -20.83M -4.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-08-20 Reiterated H.C. Wainwright Buy
May-14-20 Initiated BTIG Research Buy
Oct-02-19 Reiterated Chardan Capital Markets Buy
Sep-25-19 Initiated Chardan Capital Markets Buy
Sep-18-19 Initiated William Blair Outperform
May-31-19 Initiated H.C. Wainwright Buy
Sep-01-17 Initiated Citigroup Buy
Mar-06-17 Resumed Jefferies Buy
May-12-16 Resumed Jefferies Buy
View All

Minerva Neurosciences Inc Stock (NERV) Latest News

pulisher
10:48 AM

How buybacks impact Minerva Neurosciences Inc. stock value2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com

10:48 AM
pulisher
10:41 AM

What to do if you’re stuck in Minerva Neurosciences Inc.July 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com

10:41 AM
pulisher
10:37 AM

Is Minerva Neurosciences Inc. stock vulnerable to regulatory risks2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

10:37 AM
pulisher
10:35 AM

Is Minerva Neurosciences Inc. stock overvalued by current metricsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com

10:35 AM
pulisher
10:09 AM

Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com

10:09 AM
pulisher
10:06 AM

Can technical indicators confirm Minerva Neurosciences Inc.’s reversal2025 Market Overview & Low Risk Growth Stock Ideas - newser.com

10:06 AM
pulisher
08:27 AM

Chart based exit strategy for Minerva Neurosciences Inc.Market Growth Summary & AI Forecast for Swing Trade Picks - newser.com

08:27 AM
pulisher
08:02 AM

Minerva Neurosciences Inc. recovery potential after sell offWeekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com

08:02 AM
pulisher
01:38 AM

Automated trading signals detected on Minerva Neurosciences Inc.July 2025 Decliners & High Return Stock Watch Alerts - newser.com

01:38 AM
pulisher
Oct 10, 2025

Reversal indicators forming on Minerva Neurosciences Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Minerva Neurosciences Inc. a candidate for recovery playMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Key resistance and support levels for Minerva Neurosciences Inc.2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Parkinson Disease Pipeline Drugs 2025 Report: Emerging Drugs, Innovative Therapies, Clinical Trial Updates, and Top Companies - Barchart.com

Oct 08, 2025
pulisher
Oct 06, 2025

Would You Accumulate or Wait on JTEKT India Limited (JTEKTINDIA)Earnings Per Share Trends & Free Explosive Trading Growth - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Is Minerva Neurosciences Inc. stock dividend yield sustainableTrend Reversal & Risk Managed Trade Strategies - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Minerva Neurosciences Inc 4MNA stockMarket Correction Analysis & Outperform the Market with Aggressive Picks - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Chart based analysis of Minerva Neurosciences Inc. trendsSell Signal & High Win Rate Trade Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is it time to cut losses on Minerva Neurosciences Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

ProShares Trust ProShares UltraShort MSCI Japan Stock Analysis and ForecastStock Market Trends & Small Investment Growth Tips - earlytimes.in

Oct 03, 2025
pulisher
Oct 02, 2025

What drives CopAur Minerals Inc RFC4 stock priceInsider Buying Signals & Low Risk Trading Plans - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

What analysts say about Shutterstock Inc stockRetail Trading Trends & Budget Friendly Growth - earlytimes.in

Oct 01, 2025
pulisher
Sep 30, 2025

Does Minerva Neurosciences Inc. qualify in momentum factor screeningMarket Trend Report & Reliable Entry Point Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What drives Minerva Neurosciences Inc stock priceSell Signals and Alerts & Tap Into the Fastest-Growing Companies - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Is Farmer Bros. Co. stock a buy on dipsTrade Entry Report & Verified Entry Point Signals - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Minerva Neurosciences Inc Stock Analysis and ForecastPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What market sentiment indicators show for Algernon Pharmaceuticals Inc. (AGW0) stock2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Best data tools to analyze OSR Holdings Inc. stockJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com

Sep 28, 2025
pulisher
Sep 27, 2025

How RSPH stock behaves in tightening cyclesWeekly Gains Report & AI Powered Market Trend Analysis - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Is Dimensional ETF Trust Dimensional World stock a buy during volatile marketsPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What hedge fund moves indicate for Schroder BSC Social Impact Trust plc (783) stockEarnings Trend Report & Verified Technical Trade Signals - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Why Carlton Precious Inc. (IVH) stock is trending on social media2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com

Sep 27, 2025
pulisher
Sep 22, 2025

How to use Fibonacci retracement on SITCJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Sep 22, 2025

Minerva Neurosciences Inc Stock (NERV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):